Clinical Trials Sponsored by SAGA Innovations

Total 2135 results

University of Chicago
Innovations for Poverty Action

Recruiting

Testing Response Bias on Sensitive Topics in Self- Versus Enumerator-administered Surveys

Bias, Implicit

Colombia
Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations

Completed

Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers

Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Lebanon, Jordan, Kenya
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

Elotuzumab, Lenalidomide and Dexamethasone in Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients

Multiple Myeloma

United States
SCRI Development Innovations, LLC
Millennium Pharmaceuticals, Inc.

Completed

Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)

Metastatic Breast Cancer

United States
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

Vinflunine in Hormone Refractory Prostate Cancer (HRPC)

Prostate Cancer

United States
SCRI Development Innovations, LLC
Novartis; Genentech, Inc.

Completed

RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM

Glioblastoma Multiforme

United States
SCRI Development Innovations, LLC
Novartis; Genentech, Inc.

Completed

RAD001 Plus Bevacizumab in Metastatic Melanoma

Metastatic Melanoma

United States
SCRI Development Innovations, LLC
AstraZeneca; Genentech, Inc.

Completed

Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer

Breast Cancer | Breast Neoplasms

United States
SCRI Development Innovations, LLC
Millennium Pharmaceuticals, Inc.

Completed

Determining the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple Myeloma

Multiple Myeloma

United States
SCRI Development Innovations, LLC
GlaxoSmithKline; Novartis; Cephalon

Completed

Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy

Diffuse Large B-Cell Lymphoma

United States
MEI Pharma, Inc.
SCRI Development Innovations, LLC

Terminated

ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors

Solid Tumors

United States, United Kingdom
SCRI Development Innovations, LLC
Infinity Pharmaceuticals, Inc.

Completed

Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies

Lymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | T-cell Lymphoma

United States
MEI Pharma, Inc.
SCRI Development Innovations, LLC

Completed

Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors

Solid Tumors

United States
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer

Lung Cancer | Carcinoma, Small Cell

United States
SCRI Development Innovations, LLC
GlaxoSmithKline; Genentech, Inc.

Completed

Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors

Cancer
Northwestern University
Sage Products, Inc.

Completed

Pre-operative Preparation Using 2% Chlorhexidine Cloth For Shoulder Surgery

Post-operative Surgical Site Infections

United States
Dr. Tarit Saha

Completed

Does the Speed of Sternal Retraction Affect Postoperative Pain Outcomes

Chronic Pain

Canada
Sara Rosenblum

Completed

Metacognitive ADHD Telehealth Intervention for Work-performance Enhancement (Work-MATE)

ADHD

Israel
Sara Rosenblum

Completed

Activities of Daily Living Participation Characteristics Among School-Aged Children With Autism Spectrum Disorder

Autism Spectrum Disorder

Israel
Nakhle Saba, MD

No longer available

Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19

COVID-19

United States
Sara Guttas

Completed

SHAPE:SeeingtheHeartwithAIPoweredEcho (SHAPE)

Cardiac Disease

United States
Sara Guttas

Completed

Point-of-Care Echocardiography With Assistance Technology

Cardiac Disease

United States
Sara Farag

Completed

Urinary Retention After Total Laparoscopic Hysterectomy With Immediate Foley Catheter Removal Versus Backfill Void Trial

Voiding Disorders | Urinary Retention

United States
Sara Rosenblum

Completed

Developing and Evaluating a Meta-cognitive Intervention Amongst Adolescents With Neuro-development Disabilities (FITTED)

Adolescent Behavior
University Ghent
Sage Products, LLC

Completed

Pressure Ulcer Prevention: a Turn and Positioning System Combined With Incontinence Care and Tailored/Standard Repositioning

Pressure Ulcers | Incontinence-associated Dermatitis

Belgium
sara AbdAllah
Beni-Suef University

Unknown

Comparison Between Intrauterine Contraceptive Device Insertion During Cesarean Section Vs Conventional Application

Contraception
Meir Hospital, Kfar Saba, Israel

Unknown

Meir Medical Center Home Monitoring Clinic Registry

Patients Implanted With an ICD or CRTD.

Israel
SCRI Development Innovations, LLC
Acerta Pharma, LLC

Completed

Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

Colon Cancer

United States
SCRI Development Innovations, LLC
Novartis; Genentech, Inc.

Terminated

Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma

Intracranial Meningioma

United States
TG Therapeutics, Inc.
SCRI Development Innovations, LLC

Completed

Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies

Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Peripheral T-Cell Lymphoma

United States
Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations

Completed

Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers

Lassa Fever

United States
TG Therapeutics, Inc.
SCRI Development Innovations, LLC

Completed

TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Gastrointestinal Stromal Tumor (GIST)

United States
Aegis Medical Innovations
Applied Health Research Centre

Active, not recruiting

Feasibility Study of a Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation (LASSO-AF)

Atrial Fibrillation

United States, Canada
SCRI Development Innovations, LLC
Achieve Life Sciences

Completed

Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic Cancer (Rainier)

Pancreatic Cancer

United States
SCRI Development Innovations, LLC
Daiichi Sankyo, Inc.

Completed

Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach

Malignant Solid Tumour | Gastroesophageal Cancer

United States
SCRI Development Innovations, LLC
Novartis; Aventis Pharmaceuticals

Completed

Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer

Breast Cancer

United States
Gayle Gordillo
Vomaris Innovations

Completed

Procellera and Negative Pressure Therapy for Acute Wounds

Wound

United States
SCRI Development Innovations, LLC
Bayer; OSI Pharmaceuticals

Completed

Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib

Non-Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Sanofi; Genentech, Inc.

Completed

Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC

Non-Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
AstraZeneca; Genentech, Inc.

Completed

OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma

Kidney Cancer

United States
Atrium Innovations
Mucos Pharma GmbH, Oberhaching, Germany

Completed

The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in Adults

Osteoarthritis | Wobenzym

Germany
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer

Breast Cancer | Breast Neoplasms

United States
SCRI Development Innovations, LLC
Novartis; Genentech, Inc.

Completed

Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma

Clear Cell Renal Cell Carcinoma
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer

Lung Cancer

United States
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer

Esophagus Cancer
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma

Prostate Cancer
SCRI Development Innovations, LLC
Millennium Pharmaceuticals, Inc.

Completed

Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma

Multiple Myeloma

United States
sara nabil

Recruiting

Oraverse Versus Laser (RCT)

Reversal of Local Anesthesia in Children

Egypt
Sana Boudabbous

Recruiting

Pain Relief in Symptomatic Bone Metastases With Adjuvant Hyperthermia MR Guided HIFU (BM-RT-HIFU)

MRI | Pain | Bone Metastases | Radiotherapy

Switzerland

Clinical Trials Sponsored by SAGA Innovations

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations